Preliminary safety and activity of nivolumab and its combination with ipilimumab in recurrent glioblastoma (GBM): CHECKMATE-143. Sampson, J. H., Vlahovic, G., Sahebjam, S., Omuro, A., Baehring, J. M., Hafler, D. A., Voloschin, A., Paliwal, P., Grosso, J., Coric, V., Cloughesy, T. F., Lim, M., Reardon, D. A. AMER SOC CLINICAL ONCOLOGY. 2015

View details for DOI 10.1200/jco.2015.33.15_suppl.3010

View details for Web of Science ID 000358036900644